The troubled story of tachykinins and neurokinins.

Abstract:

:A family of peptides that shares a common C-terminal sequence (Phe-X-Gly-Leu-MetNH2) exists in mammalian and non-mammalian species. In mammals, three of these peptides (substance P, neurokinin A and neurokinin B) satisfy the criteria to be considered as neurotransmitters either in the central, peripheral or enteric nervous systems. In addition, multiple receptors for these peptides, which belong to the superfamily of G-protein-coupled receptors, exist. These receptors have distinct pharmacological features and selective agonists and antagonists are available for studying their functional roles. The latest update on nomenclature of these peptides and their receptors, which dates back to 1986, agreed to use the terms tachykinins and tachykinin NK1, NK2 and NK3 receptors. This 'nomenclature mismatch' has generated confusion that urges experts in the field of tachykinin research to provide a revised nomenclature.

journal_name

Trends Pharmacol Sci

authors

Maggi CA

doi

10.1016/s0165-6147(00)01463-2

subject

Has Abstract

pub_date

2000-05-01 00:00:00

pages

173-5

issue

5

eissn

0165-6147

issn

1873-3735

pii

S0165-6147(00)01463-2

journal_volume

21

pub_type

杂志文章
  • Quantitative approaches to analyzing imatinib-treated chronic myeloid leukemia.

    abstract::Progress in understanding the genetic changes that drive tumorigenesis has enabled the development of molecularly targeted anticancer therapy. The first small molecule targeted to a specific protein was imatinib mesylate (Gleevec, STI571), which is used to treat chronic myeloid leukemia (CML). A recent article present...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章

    doi:10.1016/j.tips.2007.03.003

    authors: Michor F

    更新日期:2007-05-01 00:00:00

  • Peptidomics for the discovery and characterization of neuropeptides and hormones.

    abstract::The discovery of neuropeptides as signaling molecules with paracrine or hormonal regulatory functions has led to trailblazing advances in physiology and fostered the characterization of numerous neuropeptide-binding G protein-coupled receptors (GPCRs) as potential drug targets. The impact on human health has been trem...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/j.tips.2015.05.009

    authors: Romanova EV,Sweedler JV

    更新日期:2015-09-01 00:00:00

  • Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors.

    abstract::Seven-transmembrane receptors are prototypic allosteric proteins with the ability to adopt numerous conformations, many of which interact with cellular partners to initiate cellular biochemical processes. Defining efficacy as the ability of ligands to stabilize some of these conformations (which, in turn, possess phys...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/j.tips.2007.06.009

    authors: Kenakin T

    更新日期:2007-08-01 00:00:00

  • The pharmacology of apoptosis.

    abstract::Apoptosis is an area of intense scientific interest, which encompasses the study of and triggers mechanisms involved in mediating the cell biology of programmed cell death. A number of low molecular weight compounds have been used to inhibit or enhance this fundamental cellular process and so apoptosis has now become ...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/s0165-6147(98)01277-2

    authors: Kinloch RA,Treherne JM,Furness LM,Hajimohamadreza I

    更新日期:1999-01-01 00:00:00

  • Characterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling.

    abstract::Recent advances in schizophrenia (SZ) research indicate that the telencephalic gamma-aminobutyric acid (GABA)ergic neurotransmission deficit associated with this psychiatric disorder probably is mediated by the hypermethylation of the glutamic acid decarboxylase 67 (GAD(67)), reelin and other GABAergic promoters. A ph...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章

    doi:10.1016/j.tips.2008.10.010

    authors: Guidotti A,Dong E,Kundakovic M,Satta R,Grayson DR,Costa E

    更新日期:2009-02-01 00:00:00

  • Gene targeting--homing in on alpha 2-adrenoceptor-subtype function.

    abstract::The alpha-adrenoceptor was subdivided into three subtypes: alpha 2A-, alpha 2B- and alpha 2C-adrenoceptors almost ten years ago. Since then, the search has been on to discover and develop subtype-selective agonists and antagonists, but as yet no major breakthrough has been made. In the past year, several strains of ge...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/s0165-6147(97)01063-8

    authors: MacDonald E,Kobilka BK,Scheinin M

    更新日期:1997-06-01 00:00:00

  • Non-genomic loss of PTEN function in cancer: not in my genes.

    abstract::Loss of function of the phosphatase and tensin homolog (PTEN) tumour suppressor contributes to the development of many cancers. However, in contrast to classical models of tumour suppression, partial loss of PTEN function appears to be frequently observed in the clinic. In addition, studies of both humans and mice wit...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/j.tips.2010.12.005

    authors: Leslie NR,Foti M

    更新日期:2011-03-01 00:00:00

  • Three-finger snake neurotoxins and Ly6 proteins targeting nicotinic acetylcholine receptors: pharmacological tools and endogenous modulators.

    abstract::Snake venom neurotoxins and lymphocyte antigen 6 (Ly6) proteins, most of the latter being membrane tethered by a glycosylphosphatidylinositol (GPI) anchor, have a variety of biological activities, but their three-finger (3F) folding combines them in one Ly6/neurotoxin family. Subsets of two groups, represented by α-ne...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/j.tips.2014.11.003

    authors: Tsetlin VI

    更新日期:2015-02-01 00:00:00

  • Techniques: Visualizing apoptosis using nuclear magnetic resonance.

    abstract::Apoptosis plays a key role in tumour biology, and the induction of apoptosis forms a cornerstone of most anticancer therapies. New developments in nuclear magnetic resonance spectroscopy (MRS) and magnetic resonance imaging (MRI) have taken these techniques far beyond their original roles as the workhorses of structur...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/S0165-6147(03)00032-4

    authors: Hakumäki JM,Brindle KM

    更新日期:2003-03-01 00:00:00

  • The elusive nature of intrinsic efficacy.

    abstract::In the discipline of pharmacology, drugs (ligands) are used as tools to elucidate the processes of biological systems. Because of this, pharmacologists strive to delineate all characteristics of drugs. Decades of research have resulted in the proposal that ligands possess two properties that are intrinsic to the ligan...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/s0165-6147(97)01138-3

    authors: Clarke WP,Bond RA

    更新日期:1998-07-01 00:00:00

  • Diverse functions of muscarinic acetylcholine receptor subtypes.

    abstract::Muscarinic acetylcholine receptor subtypes m1, m3 and m5 couple strongly to phosphatidylinositol turnover and hence to intracellular Ca2+ concentration via pertussis toxin (PTX) sensitive and insensitive G proteins. The m2 and m4 muscarinic receptor subtypes strongly inhibit adenylyl cyclase production via PTX sensiti...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:

    authors: Lechleiter J,Peralta E,Clapham D

    更新日期:1989-12-01 00:00:00

  • Blocking interactions between HIV-1 integrase and cellular cofactors: an emerging anti-retroviral strategy.

    abstract::HIV-1 integrase (IN) executes the insertion of proviral DNA into the host cell genome, an essential step in the retroviral life cycle. This is a multi-step process that starts in the cytosol and culminates in the nucleus of the infected cell. It is becoming increasingly clear that IN interacts with a wide range of dif...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/j.tips.2007.09.005

    authors: Al-Mawsawi LQ,Neamati N

    更新日期:2007-10-01 00:00:00

  • CDK inhibitors in cancer therapy: what is next?

    abstract::The pursuit for drugs that inhibit cyclin-dependent kinases (CDKs) has been an intense area of research for more than 15 years. The first-generation inhibitors, Flavopiridol and CY-202, are in late-stage clinical trials, but so far have demonstrated only modest activity. Several second-generation inhibitors are now in...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章

    doi:10.1016/j.tips.2007.10.012

    authors: Malumbres M,Pevarello P,Barbacid M,Bischoff JR

    更新日期:2008-01-01 00:00:00

  • Functional versus chemical diversity: is biodiversity important for drug discovery?

    abstract::Prospecting the full biodiversity of nature to find leads for new drugs is not necessary. Because finding leads is aimed at identifying biological activity, structure is of secondary importance. Furthermore, although natural chemical diversity might be unrivalled, functional diversity is bound to be considerably less....

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章

    doi:10.1016/s0165-6147(02)02007-2

    authors: Tulp M,Bohlin L

    更新日期:2002-05-01 00:00:00

  • Elucidating cell signaling mechanisms using antisense technology.

    abstract::Many diseases result from defects in cell signaling. Achieving an in-depth understanding of the complex mechanisms by which cells transduce extracellular signals into cellular responses in both normal and diseased systems is a crucial step in the discovery of more effective drugs to treat human diseases. Traditional a...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/s0165-6147(00)01448-6

    authors: Koller E,Gaarde WA,Monia BP

    更新日期:2000-04-01 00:00:00

  • The developing use of heterozygous mutant mouse models in brain monoamine transporter research.

    abstract::5-Hydroxytryptamine (5-HT), dopamine and norepinephrine are important monoamine neurotransmitters implicated in multiple brain mechanisms and regulated by high-affinity transmembrane monoamine transporters. Although knockout mice lacking 5-HT, dopamine or norepinephrine transporters are widely used to assess brain mon...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/j.tips.2007.01.002

    authors: Kalueff AV,Ren-Patterson RF,Murphy DL

    更新日期:2007-03-01 00:00:00

  • Distribution and anchoring of molecular forms of acetylcholinesterase.

    abstract::Molecular forms of acetylcholinesterase exhibit tissue-specific distribution, and each form is anchored to the cell surface via a particular post-translational modification of the catalytic subunit. Nibaldo Inestrosa and Alejandra Perelman review evidence that heparan sulphate proteoglycans are the extracellular matri...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/0165-6147(89)90067-9

    authors: Inestrosa NC,Perelman A

    更新日期:1989-08-01 00:00:00

  • Cancer Drug Development Using Drosophila as an in vivo Tool: From Bedside to Bench and Back.

    abstract::The fruit fly Drosophila melanogaster has been used for modeling cancer and as an in vivo tool for the validation and/or development of cancer therapeutics. The impetus for the use of Drosophila in cancer research stems from the high conservation of its signaling pathways, lower genetic redundancy, short life cycle, g...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/j.tips.2016.05.010

    authors: Yadav AK,Srikrishna S,Gupta SC

    更新日期:2016-09-01 00:00:00

  • Selective and mixed endothelin receptor antagonism in cardiovascular disease.

    abstract::Within five years of discovering endothelin (ET-1) in 1988, the first report of an orally available ET receptor antagonist was published. Within twelve years, bosentan, the first ET receptor antagonist to gain marketing authorization, was made available for the treatment of pulmonary artery hypertension (PAH). Since t...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/j.tips.2007.10.002

    authors: Dhaun N,Pollock DM,Goddard J,Webb DJ

    更新日期:2007-11-01 00:00:00

  • RGS9-2: probing an intracellular modulator of behavior as a drug target.

    abstract::Regulators of G-protein signaling (RGS proteins) comprise a large family of signal transduction molecules that modulate G-protein-coupled-receptor (GPCR) function. Among the RGS proteins expressed in the brain, RGS9-2 is very abundant in the striatum, a brain region involved in movement, motivation, mood and addiction...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章

    doi:10.1016/j.tips.2008.11.006

    authors: Traynor JR,Terzi D,Caldarone BJ,Zachariou V

    更新日期:2009-03-01 00:00:00

  • A novel way to spread drug resistance in tumor cells: functional intercellular transfer of P-glycoprotein (ABCB1).

    abstract::Intercellular transfer of proteins is a mode of communication between cells that is crucial for certain physiological processes. Chemotherapy is the treatment of choice for approximately 50% of all cancers. However, multidrug resistance mediated by drug-efflux pumps such as P-glycoprotein (Pgp) minimizes the effective...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/j.tips.2005.06.001

    authors: Ambudkar SV,Sauna ZE,Gottesman MM,Szakacs G

    更新日期:2005-08-01 00:00:00

  • Place your BETs: the therapeutic potential of bromodomains.

    abstract::Therapeutic targeting of the processes that regulate histone modification is a growing area of scientific exploration. Although most interest has concentrated on the various families of enzymes that contribute to these processes, this review focuses on emerging data demonstrating the chemical tractability and therapeu...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/j.tips.2011.12.002

    authors: Prinjha RK,Witherington J,Lee K

    更新日期:2012-03-01 00:00:00

  • Protein engineering and the study of structure--function relationships in receptors.

    abstract::Protein engineering is a powerful tool for studying relationships between receptor structure and function--providing that it is used and interpreted appropriately. Site-directed mutagenesis, deletion mutagenesis and construction of chimaeric proteins have all been used to characterize receptors. In this review, Walter...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/0165-6147(90)90009-w

    authors: Ward WH,Timms D,Fersht AR

    更新日期:1990-07-01 00:00:00

  • Hans Horst Meyer and the lipoid theory of narcosis.

    abstract::This year marks the 90th anniversary of the publication of Hans Horst Meyer's classic paper in which he proposed that the ability of a substance to produce narcosis or anesthesia is governed by its partition coefficient. In this article, Robert Lipnick describes the experiments carried out by Meyer and his colleagues ...

    journal_title:Trends in pharmacological sciences

    pub_type: 传,历史文章,杂志文章

    doi:10.1016/0165-6147(89)90025-4

    authors: Lipnick RL

    更新日期:1989-07-01 00:00:00

  • Use of transgenic mice to study voltage-dependent Ca2+ channels.

    abstract::During the past decade a great number of genes encoding high- and low-voltage-dependent Ca(2+) channels and their accessory subunits have been cloned. Studies of Ca(2+) channel structure-function relationships and channel regulation using cDNA expression in heterologous expression systems have revealed intricate detai...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/s0165-6147(00)01797-1

    authors: Muth JN,Varadi G,Schwartz A

    更新日期:2001-10-01 00:00:00

  • The hypothalamic H1 receptor: a novel therapeutic target for disrupting diurnal feeding rhythm and obesity.

    abstract::Histamine-containing neurons and histamine H1 receptors are distributed within the brain and peripheral tissues. The results of physiological and pharmacological studies have revealed that brain histamine and H1 receptors are involved in the regulation of feeding and obesity in rodents. The adipocytokine leptin regula...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/j.tips.2006.03.008

    authors: Masaki T,Yoshimatsu H

    更新日期:2006-05-01 00:00:00

  • Stimulants and the developing brain.

    abstract::For almost 70 years, children have received stimulants for the treatment of attention deficit hyperactivity disorder [ADHD (initially called hyperkinetic syndrome)], with little understanding of the long-term effects of these drugs on brain development. The maturation and refinement of the brain during childhood and a...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/j.tips.2005.03.009

    authors: Andersen SL

    更新日期:2005-05-01 00:00:00

  • Hormone and growth factor receptor-mediated regulation of phospholipase C activity.

    abstract::The broad importance of receptor-activated phosphoinositide hydrolysis in the physiological action of hormones, neurotransmitters and growth factors has sparked interest in the study of transmembrane signalling events responsible for activation of phospholipase C. As with receptors involved in regulation of adenylyl c...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/0165-6147(89)90008-4

    authors: Boyer JL,Hepler JR,Harden TK

    更新日期:1989-09-01 00:00:00

  • NSAIDs: small molecules for prevention of Alzheimer's disease or precursors for future drug development?

    abstract::Non-steroidal anti-inflammatory drugs (NSAIDs) have been considered for treatment and prevention of Alzheimer's disease (AD) for more than two decades. Biochemical markers in the brains of individuals with AD suggest that inflammation might be a driving cause of the disease that can be suppressed by drug treatment. In...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/j.tips.2007.09.004

    authors: Weggen S,Rogers M,Eriksen J

    更新日期:2007-10-01 00:00:00

  • Annexin A1 in the brain--undiscovered roles?

    abstract::Annexin A1 (ANXA1) is an endogenous protein known to have potent anti-inflammatory properties in the peripheral system. It has also been detected in the brain, but its function there is still ambiguous. In this review, we have, for the first time, collated the evidence currently available on the function of ANXA1 in t...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审

    doi:10.1016/j.tips.2007.12.003

    authors: Solito E,McArthur S,Christian H,Gavins F,Buckingham JC,Gillies GE

    更新日期:2008-03-01 00:00:00